TABLE 2.

SYNTAX Trial Outcomes in Nondiabetic Patients (N = 1,348) (19–21)

Clinical Outcome	1-Year			3-Year			5-Year
	CABG, %	PCI, %	p Value	CABG, %	PCI, %	p Value	CABG, %	PCI, %	p Value
Composite MACCE	11.8	15.1	0.08	19.3	24.9	0.014	26.3	34.1	0.002
Death/CVA/MI	6.8	6.8	0.97	11.4	13.4	0.293	15.9	19.8	0.069
All-cause death	2.6	3.0	0.68	6.1	6.9	0.519	10.9	12.0	0.48
Cardiac death	1.6	2.6	0.20	3.1	5.0	0.087	4.9	7.7	0.035
CVA	2.2	0.5	0.006	3.3	1.9	0.096	3.5	2.2	0.15
MI	2.9	4.8	0.08	3.2	7.5	<0.001	3.4	9.9	<0.001
Graft occlusion/stent thrombosis	3.8	3.4	0.72	3.4	4.3	0.345	3.9	5.6	0.14
Repeat revascularization	5.7	11.1	<0.001	10.0	16.9	<0.001	13.4	22.8	<0.001
PCI	4.8	9.6	<0.001	9.2	14.3	0.003	12.9	19.3	0.001
CABG	1.1	2.4	0.07	1.1	3.9	0.002	1.1	5.8	<0.001

CVA = cerebrovascular accident; other abbreviations as in Table 1.